Valbiotis SA (EPA:ALVAL)
France
· Delayed Price · Currency is EUR 1.150
+0.020 (1.77%)
May 29, 2025, 4:37 PM CET
Valbiotis Revenue
In the year 2024, Valbiotis had annual revenue of 176.00K EUR, down -96.28%. Valbiotis had revenue of -4.00M in the half year ending December 31, 2024, a decrease of -2,768.00%.
Revenue
176.00K
Revenue Growth
-96.28%
P/S Ratio
106.49
Revenue / Employee
4.00K
Employees
44
Market Cap
18.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.00K | -4.56M | -96.28% |
| Dec 31, 2023 | 4.73M | 3.95M | 502.93% |
| Dec 31, 2022 | 785.00K | 487.00K | 163.42% |
| Dec 31, 2021 | 298.00K | -2.79M | -90.36% |
| Dec 31, 2020 | 3.09M | 3.00M | 3,297.80% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |